A researcher at local psychiatric hospital Sheppard Pratt is gearing up to participate in clinical trials that will involve investigating the effects psilocybin, or “magic mushrooms,” can have on patients dealing with depression that has not responded well to other treatments. Dr. Scott Aaronson, director of clinical research programs at Sheppard Pratt, will be the lead investigator for a new trial to be conducted in partnership with London-based mental health startup COMPASS Pathways Inc. It will…
from https://www.bizjournals.com/baltimore/news/2020/05/04/sheppard-pratt-to-host-magic-mushroom-trials-in.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/617186721950515200
No comments:
Post a Comment